Sustained value of proadrenomedullin as mortality predictor in severe sepsis

Journal of Infection

Volumn 71, Issue 1, 2015, Pages 136-139

  Andaluz Ojeda, D ^a   Cicuendez R ^a   Calvo, D ^a   Largo, E ^a   Nogales, L ^a   Munoz M F ^a   Bueno, P ^a   Eiros, J M ^a,b   Gandia F ^a   Bermejo Martin J F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Mortality; Prediction; Proadrenomedullin; Sepsis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LACTIC ACID; PROADRENOMEDULLIN; PROCALCITONIN; ADRENOMEDULLIN; PROTEIN PRECURSOR;

ADULT; CHEMILUMINESCENCE IMMUNOASSAY; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DISEASE SEVERITY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; LETTER; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEPSIS; SEPTIC SHOCK; BLOOD; COMMUNITY-ACQUIRED INFECTIONS; COMPLICATION; PNEUMONIA;

ADRENOMEDULLIN; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; PNEUMONIA; PROTEIN PRECURSORS;

EID: 84930538141     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.02.002     Document Type: Letter

References (10)

1. España P.P., Capelastegui A., Mar C., Bilbao A., Quintana J.M., Diez R., et al. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia. J Infect 2014 Dec 11, pii:S0163-4453(14)00374-0. 10.1016/j.jinf.2014.12.003.
2. Huang D.T., Angus D.C., Kellum J.A., Pugh N.A., Weissfeld L.A., Struck J., et al. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest 2009, 136:823-831.
3. Albrich W.C., Dusemund F., Rüegger K., Christ-Crain M., Zimmerli W., Bregenzer T., et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis 2011, 11:112.
4. Krüger S., Ewig S., Giersdorf S., Hartmann O., Suttorp N., Welte T. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 2010, 182:1426-1434. German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group.
5. Bello S., Lasierra A.B., Mincholé E., Fandos S., Ruiz M.A., Vera E., et al. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. Eur Respir J 2012, 39:1144-1155.
6. Cavallazzi R., El-Kersh K., Abu-Atherah E., Singh S., Loke Y.K., Wiemken T., et al. Midregional proadrenomedullin for prognosis in community-acquired pneumonia: a systematic review. Respir Med 2014, 108:1569-1580.
7. Renaud B., Schuetz P., Claessens Y.-E., Labarère J., Albrich W., Mueller B. Proadrenomedullin improves risk of early admission to ICU score for predicting early severe community-acquired pneumonia. Chest 2012, 142:1447-1454.
8. Christ-Crain M., Morgenthaler N.G., Struck J., Harbarth S., Bergmann A., Müller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care Lond Engl 2005, 9:R816-R824.
9. Suberviola B., Castellanos-Ortega A., Ruiz Ruiz A., Lopez-Hoyos M., Santibañez M. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Med 2013, 39:1945-1952.
10. Marino R., Struck J., Maisel A.S., Magrini L., Bergmann A., Somma S. Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis. Crit Care Lond Engl 2014, 18:R34.